Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.

Journal article

Munir T. et al, (2023), N Engl J Med

Genomic Stratification of Hematological Malignancies.

Journal article

Robbe P. and Schuh A., (2023), Hemasphere, 7

LIQUID BIOPSY FOR EARLY, NON‐INVASIVE DIAGNOSIS OF EBV‐POSITIVE BURKITT LYMPHOMA IN RESOURCE LIMITED SETTINGS

Journal article

Chamba CC. et al, (2023), Hematological Oncology, 41, 334 - 335

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.

Journal article

Davies AJ. et al, (2023), Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Load More